Literature DB >> 25304610

Clinical features and outcome of SIL/TAL1-positive T-cell acute lymphoblastic leukemia in children and adolescents: a 10-year experience of the AIEOP group.

Mariella D'Angiò1, Maria G Valsecchi2, Anna M Testi3, Valentino Conter4, Vittorio Nunes1, Rosanna Parasole5, Antonella Colombini4, Nicola Santoro6, Stefania Varotto7, Maurizio Caniglia8, Daniela Silvestri9, Caterina Consarino10, Laura Levati11, Elisa Magrin7, Franco Locatelli12, Giuseppe Basso7, Robin Foà1, Andrea Biondi4, Gianni Cazzaniga11.   

Abstract

Entities:  

Keywords:  SIL/TAL1; acute lymphoblastic leukemia; children and adolescents

Mesh：

Substances：

Year:  2014        PMID： 25304610      PMCID： PMC4281327          DOI： 10.3324/haematol.2014.112151

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A pediatric oncology group study.

Authors:  R O Bash; S Hall; C F Timmons; W M Crist; M Amylon; R G Smith; R Baer
Journal:  Blood       Date:  1995-07-15       Impact factor: 22.113

2.  The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols.

Authors:  Martine van Grotel; Jules P P Meijerink; H Berna Beverloo; Anton W Langerak; Jessica G C A M Buys-Gladdines; Pauline Schneider; Tim S Poulsen; Monique L den Boer; Martin Horstmann; Willem A Kamps; Anjo J P Veerman; Elisabeth R van Wering; Max M van Noesel; Rob Pieters
Journal:  Haematologica       Date:  2006-09       Impact factor: 9.941

3.  Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemia.

Authors:  M J Pongers-Willemse; T Seriu; F Stolz; E d'Aniello; P Gameiro; P Pisa; M Gonzalez; C R Bartram; E R Panzer-Grümayer; A Biondi; J F San Miguel; J J van Dongen
Journal:  Leukemia       Date:  1999-01       Impact factor: 11.528

4.  Clinical significance of TAL1 gene alteration in childhood T-cell acute lymphoblastic leukemia and lymphoma.

Authors:  A Kikuchi; Y Hayashi; S Kobayashi; R Hanada; K Moriwaki; K Yamamoto; J Fujimoto; Y Kaneko; S Yamamori
Journal:  Leukemia       Date:  1993-07       Impact factor: 11.528

5.  Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951.

Authors:  Hélène Cavé; Stefan Suciu; Claude Preudhomme; Bruce Poppe; Alain Robert; Anne Uyttebroeck; Michèle Malet; Patrick Boutard; Yves Benoit; Laurent Mauvieux; Patrick Lutz; Françoise Méchinaud; Nathalie Grardel; Francoise Mazingue; Madeleine Dupont; Geneviève Margueritte; Marie-Pierre Pages; Yves Bertrand; Emmanuel Plouvier; Ghislaine Brunie; Christian Bastard; Dominique Plantaz; Isabel Vande Velde; Anne Hagemeijer; Frank Speleman; Michel Lessard; Jacques Otten; Etienne Vilmer; Nicole Dastugue
Journal:  Blood       Date:  2003-09-22       Impact factor: 22.113

6.  Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: a Pediatric Oncology Group study.

Authors:  R O Bash; W M Crist; J J Shuster; M P Link; M Amylon; J Pullen; A J Carroll; G R Buchanan; R G Smith; R Baer
Journal:  Blood       Date:  1993-04-15       Impact factor: 22.113

7.  Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.

Authors:  Paola Ballerini; Judith Landman-Parker; Jean Michel Cayuela; Vahid Asnafi; Myriam Labopin; Virginie Gandemer; Yves Perel; Gérard Michel; Thierry Leblanc; Claudine Schmitt; Sylvie Fasola; Anne Hagemejier; François Sigaux; Marie Françoise Auclerc; Luc Douay; Guy Leverger; André Baruchel
Journal:  Haematologica       Date:  2008-10-02       Impact factor: 9.941

8.  Low incidence of TAL1 gene rearrangements in adult acute lymphoblastic leukemia: A cancer and leukemia group B study (8762)

Authors: 
Journal:  Clin Cancer Res       Date:  1995-04       Impact factor: 12.531

9.  Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL).

Authors:  M C Bene; G Castoldi; W Knapp; W D Ludwig; E Matutes; A Orfao; M B van't Veer
Journal:  Leukemia       Date:  1995-10       Impact factor: 11.528

10.  Molecular characterization of a new recombination of the SIL/TAL-1 locus in a child with T-cell acute lymphoblastic leukaemia.

Authors:  Emanuela Carlotti; Francesca Pettenella; Ricardo Amaru; Sarah Slater; T Andrew Lister; Tiziano Barbui; Giuseppe Basso; Giovanni Cazzaniga; Alessandro Rambaldi; Andrea Biondi
Journal:  Br J Haematol       Date:  2002-09       Impact factor: 6.998
View more
  7 in total

1.  Early T-cell precursor acute lymphoblastic leukemia and other subtypes: a retrospective case report from a single pediatric center in China.

Authors:  Xiaoming Liu; Yao Zou; Li Zhang; Xiaojuan Chen; Wenyu Yang; Ye Guo; Yumei Chen; Yingchi Zhang; Xiaofan Zhu
Journal:  J Cancer Res Clin Oncol       Date:  2021-03-02       Impact factor: 4.553

2.  Clinico-Hematological Profile and Copy Number Abnormalities in a Cohort of STIL-TAL1 and NUP214-ABL1 Positive Pediatric T-Cell Acute Lymphoblastic Leukemia.

Authors:  Nilamani Patra; Minu Singh; Pankaj Sharma; Amita Trehan; Shano Naseem; Deepak Bansal; Prateek Bhatia
Journal:  Indian J Hematol Blood Transfus       Date:  2021-01-25       Impact factor: 0.915

Review 3.  Stem Cell Leukemia: how a TALented actor can go awry on the hematopoietic stage.

Authors:  N C Correia; M-L Arcangeli; F Pflumio; J T Barata
Journal:  Leukemia       Date:  2016-06-13       Impact factor: 11.528

Review 4.  Interstitial Deletions Generating Fusion Genes.

Authors:  Ioannis Panagopoulos; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2021 May-Jun       Impact factor: 4.069

Review 5.  Minimal Residual Disease in Acute Lymphoblastic Leukemia: Technical and Clinical Advances.

Authors:  Irene Della Starza; Sabina Chiaretti; Maria S De Propris; Loredana Elia; Marzia Cavalli; Lucia A De Novi; Roberta Soscia; Monica Messina; Antonella Vitale; Anna Guarini; Robin Foà
Journal:  Front Oncol       Date:  2019-08-07       Impact factor: 6.244

6.  MAP3K7 is recurrently deleted in pediatric T-lymphoblastic leukemia and affects cell proliferation independently of NF-κB.

Authors:  David M Cordas Dos Santos; Juliane Eilers; Alfonso Sosa Vizcaino; Elena Orlova; Martin Zimmermann; Martin Stanulla; Martin Schrappe; Kathleen Börner; Dirk Grimm; Martina U Muckenthaler; Andreas E Kulozik; Joachim B Kunz
Journal:  BMC Cancer       Date:  2018-06-18       Impact factor: 4.430

Review 7.  The Key Roles of PTEN in T-Cell Acute Lymphoblastic Leukemia Development, Progression, and Therapeutic Response.

Authors:  Alberto M Martelli; Francesca Paganelli; Antonietta Fazio; Chiara Bazzichetto; Fabiana Conciatori; James A McCubrey
Journal:  Cancers (Basel)       Date:  2019-05-06       Impact factor: 6.639
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.